Ke Wang
Sichuan University
25 Papers
117 Citations
Ke Wang is an academic researcher from Sichuan University. The author has contributed to research in topics: COPD & Medicine. The author has an hindex of 13, co-authored 25 publications.
Chat about Author
Papers
VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Xuemei Ou,Wan-Cheng Li,Dai-Shun Liu,Yan-Ping Li,Fuqiang Wen,Yulin Feng,Shang-Fu Zhang,Xiang-Yang Huang,Tao Wang,Ke Wang,Xun Wang,Lei Chen +11 more
TL;DR: Results suggest that the VEGFR-2 inhibitor, SU5416, attenuates histopathologic fibroplasias and collagen deposition by regulating angiogenesis and inflammation in the lung.
66
Macrolides attenuate mucus hypersecretion in rat airways through inactivation of NF-kappaB.
TL;DR: To examine the effect of a 14‐membered ring macrolide on airway mucus hypersecretion in rats treated with LPS, a large number of animals were treated with both LPS and LPS.
46
Validation of a venous thromboembolism risk assessment model in hospitalized chinese patients: a case-control study.
Haixia Zhou,Lan Wang,Xiao-Ling Wu,Yong-Jiang Tang,Jing Yang,Bo Wang,Yu Yan,Binmiao Liang,Ke Wang,Xuemei Ou,Maoyun Wang,Yulin Feng,Qun Yi +12 more
TL;DR: The Caprini RAM can be used to effectively stratify hospitalized Chinese patients into VTE risk categories based on individual risk factors, and further stratification of this group of patients is needed.
39
Simvastatin attenuates experimental small airway remodelling in rats.
Xue Mei Ou,Fu Qiang Wen,Bruce D. Uhal,Yu Lin Feng,Xiang Yang Huang,Tao Wang,Ke Wang,Dai Shun Liu,Xun Wang,Lei Chen +9 more
TL;DR: The aim of this study was to assess the beneficial effects of simvastatin on cigarette smoke‐induced small airway remodeling in rats and to establish a protocol to evaluate the use of this drug in clinical practice.
34
•Journal Article
Long-term non-invasive positive pressure ventilation in severe stable chronic obstructive pulmonary disease: a meta-analysis.
Hong Chen,Bin-Miao Liang,Zhi-Bo Xu,Yong-Jiang Tang,Ke Wang,Jun Xiao,Qun Yi,Jian Sun,Yu-Lin Feng +8 more
TL;DR: Patients with severe stable COPD can gain some substantial treatment benefits when using NIPPV, especially improvements in gas change, dyspnea and sleep quality, and the benefits for exercise tolerance, mood, survival and mortality remained unclear.
28